Fidelity Investments’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34K | Buy |
24,317
+11,738
| +93% | +$16.4K | ﹤0.01% | 4075 |
|
|
2025
Q1 | $20.3K | Buy |
12,579
+7,839
| +165% | +$12.6K | ﹤0.01% | 4220 |
|
|
2024
Q4 | $5.97K | Sell |
4,740
-3,771
| -44% | -$4.75K | ﹤0.01% | 4622 |
|
|
2024
Q3 | $16K | Buy |
8,511
+2,610
| +44% | +$4.91K | ﹤0.01% | 4267 |
|
|
2024
Q2 | $43.7K | Buy |
5,901
+2,999
| +103% | +$22.2K | ﹤0.01% | 3680 |
|
|
2024
Q1 | $22.7K | Sell |
2,902
-26
| -0.9% | -$204 | ﹤0.01% | 3961 |
|
|
2023
Q4 | $14.9K | Sell |
2,928
-212
| -7% | -$1.08K | ﹤0.01% | 4086 |
|
|
2023
Q3 | $18.6K | Buy |
3,140
+2,860
| +1,021% | +$16.9K | ﹤0.01% | 3849 |
|
|
2023
Q2 | $2.08K | Buy |
280
+266
| +1,900% | +$1.97K | ﹤0.01% | 4584 |
|
|
2023
Q1 | $128 | Buy |
+14
| New | +$128 | ﹤0.01% | 4880 |
|
|
2020
Q3 | – | Sell |
-6
| Closed | – | – | 3659 |
|
|
2020
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 3564 |
|
|
2020
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 3603 |
|
|
2019
Q4 | $0 | Buy |
+6
| New | – | ﹤0.01% | 3763 |
|